Europe/Asia USA
Bachem AG Bachem Americas, Inc.
Hauptstrasse 144 3132 Kashiwa Street
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA
Tel +41 61 935 2323 Tel +1 888 422 2436
Fax +41 61 935 2325 +1 888 4BACHEM
E-mail +1 310 539 4171
  Fax +1 310 539 9428


First half 2015: Record sales and solid profit growth

28. Aug 2015

Bubendorf/Basel, August 28, 2015 – Bachem Group (SIX: BANB) increased its sales by about 15% to nearly 100 million CHF in the first half of 2015 (H1 2014: 86.7 million CHF). Group sales in local currency (LC) for the first half were higher than in any other half-year period since the company’s founding. Generics sales rose by approx. 9% in LC to 49.3 million CHF and sales of research ingredients were also very strong in both the catalog products and custom synthesis business. Bachem achieved further stellar growth in the New Chemical Entities (NCEs) business, where sales rose by more than 22% in LC. Despite negative currency effects, EBITDA advanced to 26.8 million CHF and EBIT to 17.6 million CHF. Excluding last year’s extraordinary gain of 2.0 million CHF on the divestment of the immunology product line, EBIT for the period was up by about 22%. Net income rose to 12.6 million CHF. In view of the pleasing first-half results, the orders on hand and current market developments, 2015 is expected to be a very good year.


Press Release  

Half-Year Report